GUFICBIO.BO
Gufic Biosciences Limited
BSEINREQUITY
Healthcare
DELAYED
Last price
432.90
▲ 18.60 (4.49%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
416.00
Prev close
414.30
Day high
437.50
Day low
416.00
Volume
18.00K
Market cap
$42.92B
P/E (TTM)
58.47
52W range
267.50 – 447.85
Day trading desk
Gap from prior close
+0.41%
Prior close 414.30
VWAP
430.17
+0.63% from price
Relative volume
2.53×
Unusually busy
Session range
5.17%
416.00 – 437.50
Position in range
79%
Near session high
ATR (14D)
15.88
3.67% of price
Prior day high
422.45
PDH
Prior day low
411.50
PDL
Bid / ask spread
—
Quote not published
Session volume
35.88K
Avg 14.17K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+2.78%
+4.1%
1M
+14.83%
+11.1%
3M
+36.13%
+33.0%
6M
+47.17%
+36.1%
YTD
+28.55%
+16.3%
1Y
+21.72%
+1.7%
3Y
+67.24%
-6.9%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on GUFICBIO.BO open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
77.71M
Total on file
Fundamentals
Market cap$42.92B
Enterprise value$46.84B
Revenue (TTM)$9.81B
Gross profit$5.37B
EBITDA$1.60B
Net income$734.57M
EPS (TTM)$7.32
Free cash flow—
Total cash$621.86M
Total debt$4.05B
Book value / share$66.31
Shares outstanding100.28M
Float25.86M
Short % of float—
Dividend yield0.02%
Beta (5Y)-0.05
Valuation & profitability ratios
Trailing P/E58.47
Forward P/E182.91
PEG ratio—
Price / sales—
Price / book6.45
EV / revenue4.77
EV / EBITDA29.28
Gross margin54.77%
Operating margin14.92%
Profit margin7.49%
Return on equity—
Return on assets—
Debt / equity60.87
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Total revenue | $8.13B | $7.46B | $7.70B | $6.80B | +9.0% |
| Operating revenue | $8.13B | $7.46B | $7.70B | $6.80B | +9.0% |
| Cost of revenue | $4.40B | $3.82B | $3.99B | $3.41B | +15.0% |
| Gross profit | $3.73B | $3.63B | $3.70B | $3.39B | +2.7% |
| Research & development | $104.88M | $56.10M | $54.13M | $51.56M | +86.9% |
| Selling, general & admin | $278.29M | $261.69M | $207.14M | $208.57M | +6.3% |
| Total operating expense | $2.53B | $2.46B | $2.38B | $2.24B | +2.7% |
| Operating income | $1.21B | $1.17B | $1.33B | $1.15B | +2.7% |
| Net interest income | -$349.22M | -$229.45M | -$153.77M | -$68.11M | -52.2% |
| Pre-tax income | $865.49M | $941.43M | $1.16B | $1.07B | -8.1% |
| Tax provision | $223.36M | $244.95M | $295.36M | $270.16M | -8.8% |
| Net income | $642.15M | $696.50M | $861.36M | $797.05M | -7.8% |
| Net income to common | $642.15M | $696.50M | $861.36M | $797.05M | -7.8% |
| Basic EPS | 6.40 | 6.95 | 8.74 | 8.22 | -7.8% |
| Diluted EPS | 6.40 | 6.95 | 8.74 | 8.22 | -7.8% |
| EBIT | $1.22B | $1.17B | $1.30B | $1.13B | +3.9% |
| EBITDA | $1.53B | $1.38B | $1.47B | $1.36B | +10.3% |
| Basic shares | 100.28M | 100.28M | 98.52M | 96.94M | +0.0% |
| Diluted shares | 100.28M | 100.28M | 98.52M | 96.94M | +0.0% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $621.86M | $157.23M | $11.37M | $286.02M | +295.5% |
| Cash & short-term investments | $621.86M | $157.23M | $11.37M | $286.02M | +295.5% |
| Accounts receivable | $2.97B | $3.15B | $3.30B | $2.05B | -5.5% |
| Inventory | $3.24B | $2.17B | $2.00B | $1.83B | +49.6% |
| Total current assets | $8.02B | $6.25B | $6.00B | $4.64B | +28.4% |
| Property, plant & equipment | $5.19B | $5.25B | $4.74B | $3.28B | -1.1% |
| Goodwill & intangibles | $61.64M | $63.44M | $56.19M | $6.79M | -2.8% |
| Total assets | $13.42B | $11.69B | $10.93B | $8.61B | +14.8% |
| Total current liabilities | $5.18B | $3.88B | $3.72B | $2.88B | +33.6% |
| Current debt | $2.80B | $1.80B | $1.63B | $1.21B | +55.7% |
| Long-term debt | $1.05B | $1.30B | $1.54B | $1.91B | -19.5% |
| Total debt | $4.05B | $3.36B | $3.33B | $3.34B | +20.4% |
| Total liabilities | $6.77B | $5.68B | $5.60B | $5.13B | +19.2% |
| Retained earnings | $4.84B | $4.21B | $3.52B | $2.67B | +15.0% |
| Shareholder equity | $6.65B | $6.01B | $5.33B | $3.48B | +10.6% |
| Working capital | $2.84B | $2.37B | $2.28B | $1.76B | +20.0% |
| Net tangible assets | $6.59B | $5.95B | $5.27B | $3.47B | +10.8% |
| Shares issued | 100.28M | 100.28M | 100.28M | 96.94M | +0.0% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Net income | $642.13M | $696.49M | $861.36M | $797.05M | -7.8% |
| Depreciation & amortisation | $308.33M | $210.64M | $170.17M | $222.81M | +46.4% |
| Stock-based compensation | $694.00K | $1.04M | — | — | -33.3% |
| Change in working capital | -$948.28M | $74.43M | -$1.30B | -$1.35B | -1,374.1% |
| Operating cash flow | $451.39M | $1.23B | -$74.57M | -$265.87M | -63.2% |
| Capital expenditure | -$311.81M | -$755.25M | -$1.13B | -$1.88B | +58.7% |
| Investing cash flow | -$309.64M | -$707.77M | -$1.02B | -$1.91B | +56.3% |
| Dividends paid | -$10.03M | -$10.03M | -$9.72M | -$10.44M | 0.0% |
| Financing cash flow | $322.87M | -$372.04M | $823.81M | $2.34B | +186.8% |
| Free cash flow | $139.58M | $470.42M | -$1.20B | -$2.14B | -70.3% |
| End cash position | $621.86M | $157.23M | $11.37M | $286.02M | +295.5% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $2.52B | $2.31B | $2.37B | $2.24B | $2.05B | +8.8% |
| Operating revenue | $2.52B | $2.31B | $2.37B | $2.24B | $2.05B | +8.8% |
| Cost of revenue | $1.15B | $1.01B | $1.04B | $1.01B | $896.68M | +13.8% |
| Gross profit | $1.37B | $1.30B | $1.33B | $1.23B | $1.15B | +5.0% |
| Total operating expense | $973.09M | $1.05B | $1.03B | $973.69M | $968.22M | -7.4% |
| Operating income | $395.62M | $252.86M | $300.73M | $255.82M | $185.30M | +56.5% |
| Net interest income | -$94.37M | -$83.56M | -$95.84M | -$92.34M | -$84.00M | -12.9% |
| Pre-tax income | $289.51M | $177.20M | $226.04M | $172.74M | $105.25M | +63.4% |
| Tax provision | $70.55M | $52.97M | $57.81M | $42.04M | $28.05M | +33.2% |
| Net income | $218.96M | $124.24M | $168.24M | $130.70M | $77.19M | +76.2% |
| Net income to common | $218.96M | $124.24M | $168.24M | $130.70M | $77.19M | +76.2% |
| Basic EPS | 2.18 | 1.24 | 1.68 | 1.30 | 0.77 | +75.8% |
| Diluted EPS | 2.18 | 1.24 | 1.68 | 1.30 | 0.77 | +75.8% |
| EBIT | $383.88M | $260.76M | $321.89M | $265.08M | $189.25M | +47.2% |
| EBITDA | $460.37M | $337.68M | $399.62M | $342.27M | $267.68M | +36.3% |
| Basic shares | 100.44M | 100.19M | 100.14M | 100.54M | 100.25M | +0.3% |
| Diluted shares | 100.44M | 100.19M | 100.14M | 100.54M | 100.25M | +0.3% |
| Line item | 2026-03-31 | 2025-09-30 | 2025-03-31 | YoY |
|---|---|---|---|---|
| Cash & equivalents | $621.86M | $746.00M | $157.23M | -16.6% |
| Cash & short-term investments | $762.17M | $880.79M | $157.23M | -13.5% |
| Accounts receivable | $2.97B | $3.24B | $3.15B | -8.2% |
| Inventory | $3.24B | $2.30B | $2.17B | +41.3% |
| Total current assets | $8.02B | $7.27B | $6.25B | +10.3% |
| Property, plant & equipment | $5.07B | $5.13B | $5.25B | -1.1% |
| Goodwill & intangibles | $61.64M | $62.66M | $63.44M | -1.6% |
| Total assets | $13.42B | $12.71B | $11.69B | +5.6% |
| Total current liabilities | $5.18B | $4.70B | $3.88B | +10.3% |
| Current debt | $2.80B | $2.29B | $1.80B | +22.5% |
| Long-term debt | $1.05B | $1.18B | $1.30B | -10.9% |
| Total debt | $4.05B | $3.69B | $3.36B | +9.6% |
| Total liabilities | $6.77B | $6.40B | $5.68B | +5.9% |
| Retained earnings | — | — | $4.21B | — |
| Shareholder equity | $6.65B | $6.31B | $6.01B | +5.4% |
| Working capital | $2.84B | $2.58B | $2.37B | +10.4% |
| Net tangible assets | $6.59B | $6.25B | $5.95B | +5.4% |
| Shares issued | 100.28M | 100.28M | 100.28M | 0.0% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2018 | 0.61 | 0.51 | -16.4% |
| Mar 2018 | 0.79 | 0.39 | -50.6% |
| Dec 2017 | 0.61 | 0.75 | +23.0% |
| Sep 2017 | 0.37 | 0.68 | +83.7% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $0 | — |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders77.50%
Held by institutions3.55%
Institutions holding10
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
424.66
+1.94% from price
SMA 20
408.85
+5.88% from price
SMA 50
391.66
+10.53% from price
SMA 100
351.03
+23.32% from price
SMA 200
334.21
+29.53% from price
EMA 12
418.57
+3.42% from price
EMA 26
407.53
+6.23% from price
EMA 50
390.71
+10.80% from price
RSI (14)
63.9
Neutral
MACD (12,26,9)
11.05
Hist 0.19
ATR (14)
15.88
3.67% of price
Realised vol 30D
30.8%
Annualised
Bollinger upper
445.68
20, 2σ
Bollinger lower
372.02
20, 2σ
50 / 200 cross
Golden
391.66 vs 334.21
Trend bias
Above 200
+29.53%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.04
Less volatile than market
Correlation to SPY
-0.01
Largely independent
Realised vol 30D
30.8%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-28.4%
Peak to trough
Max drawdown 5Y
-44.3%
Peak to trough
ATR 14
15.88
3.67% of price
Beta (reported)
-0.05
5Y monthly, from filing
Dividends & splits
Forward rate$0.10 / yr
Forward yield0.02%
5-year avg yield0.04%
Payout ratio1.37%
Ex-dividend dateAug 28, 2026
Next pay date—
Last split—
Split date—
Headlines
Raphinha, Lopez hit braces as Barcelona trounce Elche
AFP · 20m ago
Amorim starts Serie A life with Milan win, Juve edge Frosinone
AFP · 23m ago
Lawsuit filed in Napali coast ‘doors-off’ helicopter tour crash
The Honolulu Star-Advertiser · 23m ago
Does Billionaire Bill Ackman Know Something Wall Street Doesn’t? He Invested in These 2 Stocks That Have Dropped 33% and 18% Over the Past Year
Motley Fool · 24m ago
Liquor industry struggles grow with another Chapter 7 filing
TheStreet · 26m ago
Media Advisory: Housing Announcement in Toronto
CNW Group · 29m ago
Dow Jones Futures Due With Market At Key Point; Nvidia, Tariffs, Warsh In Focus
Investor's Business Daily · 35m ago
Axsome Therapeutics Stock Is Up 16% Year to Date. Why Wall Street Thinks It Has Even More Room to Run
Motley Fool · 39m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.